The latest biotech news

News and Trends 20 Jun 2019

Spider Silk Could Improve Organoids for Drug Development

The Stockholm-based organoids company BioLamina has teamed up with the recombinant spider silk Stockholm startup Spiber Technologies to develop organoids that are more accurate tissue models than those used currently. Organoids are gaining popularity as a drug testing tool due to their capacity for modeling human tissue in 3D, which is more representative than 2D […]

June 20, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 19 Jun 2019

Scientists Grow Head and Neck Cancer Organoids to Personalize Chemotherapy

A team of Dutch researchers has developed the first 3D organoids from patients’ head and neck cancer cells that can be kept alive for a long time, giving physicians a model to test which cancer treatments are the most effective for each patient. Head and neck cancer is an aggressive disease that often requires harsh […]

June 19, 2019 - 3 minutesmins - By Jonathan Smith

ovarian cancer astrazeneca merck lynparza dna repair

News and Trends 19 Jun 2019

EU Gives Lynparza Green Light as First-Line Ovarian Cancer Treatment

The DNA damage repair drug olaparib (Lynparza), developed by AstraZeneca and Merck, has been approved by the EU as a first-line treatment preventing the return of ovarian cancer after initial chemotherapy. The drug has already been approved by the EU and the FDA as a maintenance treatment for relapsed ovarian cancer, and as a therapy […]

June 19, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 18 Jun 2019

Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure

The Belgian company Imcyse has raised €35M in a Series B round to develop a potential cure for chronic autoimmune conditions including type 1 diabetes and multiple sclerosis. Imcyse will use the money to fund phase II trials of a peptide-based treatment for type 1 diabetes. The funds will also help the company to launch […]

June 18, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Jun 2019

Dutch Biotech Boosts Hepatitis B Vaccine Effectiveness

Phase II results from Dutch biotech CyTuVax show its enhanced hepatitis B vaccine reduces non-responders by 13%. Around 15% of people receiving vaccines for hepatitis B fail to produce antibodies that protect them against the infection. These non-responders are often given more injections of the vaccine in an attempt to trigger the immune system, but […]

June 18, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 17 Jun 2019

Swiss Anti-Aging Treatment Gives the Elderly Healthier Muscles

An anti-aging dietary supplement developed by the Swiss biotech Amazentis to combat age-related muscle weakening has improved the health of muscle cells in a first-in-human study. Mitochondria are parts of the cell that generate energy, and are important for muscle movement. As we age, damaged mitochondria begin to build up in muscle cells, possibly contributing […]

June 17, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Jun 2019

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

Zynteglo, a gene therapy developed by the US company bluebird bio for the treatment of beta-thalassemia, will cost European healthcare systems more than €1.5M per patient. Following the approval of the treatment earlier this month, bluebird bio has now released the pricing plan of Zynteglo. Healthcare systems in Europe will need to pay €315,000 upfront, […]

June 14, 2019 - 1 minutemin - By Jonathan Smith

News and Trends 14 Jun 2019

French Biotech Raises €20M to Prevent Hearing Loss

The hearing loss biotech Sensorion has issued bonds to raise €20M, which it will use to fund the phase II development for first-in-class drugs treating hearing loss and severe vertigo. The money will pay for phase II trials of Sensorion’s two most advanced treatments, which are small molecule drugs to treat sudden deafness and acute […]

June 14, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Jun 2019

French Startup to Produce Sustainable Textile Dyes Using Microbes

Paris-based PILI has raised €3.6M that will take its technology to produce dyes through microbial fermentation to an industrial scale. Founded in 2015, PILI seeks to disrupt the unsustainable production of dyes. Just in the textile industry, dyes are a €8B market. However, the production of these chemicals relies on petrochemical processes that require toxic […]

June 13, 2019 - 2 minutesmins - By Clara Rodríguez Fernández

genmab janssen blood cancer multiple myeloma

News and Trends 11 Jun 2019

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug Darzalex in certain types of blood cancer. Genmab will develop the antibody treatment until it completes clinical proof-of-concept studies in the blood cancers multiple myeloma and diffuse large B-cell lymphoma. At that point, Janssen will […]

June 11, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 7 Jun 2019

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR Therapeutics, paying up to €890M ($1B) to develop treatments for genetic diseases causing muscle weakness using the gene editing tool CRISPR/Cas9. The deal includes €155M ($175M) paid upfront, and potential future payments based on achieving developmental milestones. In exchange, Vertex […]

June 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 5 Jun 2019

Highlights from European Biotech at ASCO 2019

European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research at the biggest cancer conference of the year, ASCO 2019. This year’s conference has drawn fewer big blockbuster headlines than other years, but there was plenty to see nonetheless. There were results from many different clinical trials by big pharma […]

June 5, 2019 - 5 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Spider Silk Could Improve Organoids for Drug Development

Scientists Grow Head and Neck Cancer Organoids to Personalize Chemotherapy

EU Gives Lynparza Green Light as First-Line Ovarian Cancer Treatment

Belgian Biotech’s €35M Series B to Fund Potential Type 1 Diabetes Cure

Dutch Biotech Boosts Hepatitis B Vaccine Effectiveness

Swiss Anti-Aging Treatment Gives the Elderly Healthier Muscles

First Gene Therapy for Beta Thalassemia Will Cost Over €1.5M

French Biotech Raises €20M to Prevent Hearing Loss

French Startup to Produce Sustainable Textile Dyes Using Microbes

Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster

CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M

Highlights from European Biotech at ASCO 2019

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!